Journal of Inflammation Research-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2237984, encodeId=57b0223e9842c, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：16 April 2024 Submission created 18 June 2024 Peer review selection 13 August 2024 Report sent to the Editor-in-Chief 17 August 2024 Report: revise with changes 15 October 2024 Resubmitted manuscript received 8 November 2024 Sent to Editor-in-Chief for acceptance or rejection 14 November 2024 Accepted for publication 之前网站上看到了很多人分享的经验，对自己有一定的帮助，这个时间线供大家参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f279053145, createdName=ms4000002068072868, createdTime=Wed Nov 20 14:35:42 CST 2024, time=2024-11-20, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2237751, encodeId=9e6e223e75126, content=大家2a用了多久到下一步呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Tue Nov 19 10:53:40 CST 2024, time=2024-11-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2238262, encodeId=a3a6223826243, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：目前投出去1周，现在是1AB，不知道还有多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=051e2959338, createdName=caoyuzhi01, createdTime=Thu Nov 21 20:35:25 CST 2024, time=2024-11-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2237772, encodeId=cb0d223e772b9, content=我觉得这个杂志很不错，已online 2篇，靠谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40ac3080545, createdName=liangyan0327, createdTime=Tue Nov 19 12:35:27 CST 2024, time=2024-11-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193170, encodeId=dd4721931e00d, content=wb是要整膜的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Thu Mar 14 14:20:51 CST 2024, time=2024-03-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2229945, encodeId=6eb72229945a9, content=请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Wed Oct 09 13:33:16 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2229720, encodeId=d12d2229e2096, content=10月1日投稿，10月2号收到邮件，没有要WB膜和原始数据，邮件内容如下：我们认为有必要提醒您，由于提交量的增加，在决定将您的手稿发送给同行评审之前，最初的期刊适用性和合规性检查将被推迟。目前，这一阶段平均需要30天，我们知道这比您通常期望我们提供的服务要长得多。请允许我们向您保证，这次延迟只是暂时的。我们知道你选择在《炎症研究杂志》上发表文章，部分原因是我们长期以来的快速发表历史。目前是1A_2的状态，已经过了一周了，难道真的需要等30天么？各位投过的小伙伴个情况持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff4d5246870, createdName=爱臭美的小女孩, createdTime=Tue Oct 08 09:09:31 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237308, encodeId=39a3223e308fd, content=该期刊的审稿速度较快，通常在3-4周内完成同行评审，编辑会在2-14天内做出决定。 对文章的创新性要求较高，文章需使用英语撰写，控制重复率在10%以内，并且包含图表、公式、数据等元素。图片和图表的格式需遵循特定要求，如TIFF、EPS、JPEG格式，彩色图片分辨率需≥300dpi。 该期刊对国人友好，国人发文占比约为60%以上。 生信领域友好，但自引率有所增加，需要注意选择其他自引率较低的期刊作为备选。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 22:31:53 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237007, encodeId=3c39223e00740, content=大家因为找不到审稿人，被拒稿的人多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Thu Nov 14 23:54:16 CST 2024, time=2024-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2236622, encodeId=4a072236622df, content=各位的稿件2e状态持续多久呀？我的已经10天了还没变化……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Nov 13 01:11:58 CST 2024, time=2024-11-13, status=1, ipAttribution=江苏省)]

2024-11-20 ms4000002068072868 来自青海省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：炎症
经验分享：16 April 2024 Submission created
18 June 2024 Peer review selection
13 August 2024 Report sent to the Editor-in-Chief
17 August 2024 Report: revise with changes
15 October 2024 Resubmitted manuscript received
8 November 2024 Sent to Editor-in-Chief for acceptance or rejection
14 November 2024 Accepted for publication
之前网站上看到了很多人分享的经验，对自己有一定的帮助，这个时间线供大家参考

5 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237984, encodeId=57b0223e9842c, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：16 April 2024 Submission created 18 June 2024 Peer review selection 13 August 2024 Report sent to the Editor-in-Chief 17 August 2024 Report: revise with changes 15 October 2024 Resubmitted manuscript received 8 November 2024 Sent to Editor-in-Chief for acceptance or rejection 14 November 2024 Accepted for publication 之前网站上看到了很多人分享的经验，对自己有一定的帮助，这个时间线供大家参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f279053145, createdName=ms4000002068072868, createdTime=Wed Nov 20 14:35:42 CST 2024, time=2024-11-20, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2237751, encodeId=9e6e223e75126, content=大家2a用了多久到下一步呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Tue Nov 19 10:53:40 CST 2024, time=2024-11-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2238262, encodeId=a3a6223826243, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：目前投出去1周，现在是1AB，不知道还有多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=051e2959338, createdName=caoyuzhi01, createdTime=Thu Nov 21 20:35:25 CST 2024, time=2024-11-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2237772, encodeId=cb0d223e772b9, content=我觉得这个杂志很不错，已online 2篇，靠谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40ac3080545, createdName=liangyan0327, createdTime=Tue Nov 19 12:35:27 CST 2024, time=2024-11-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193170, encodeId=dd4721931e00d, content=wb是要整膜的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Thu Mar 14 14:20:51 CST 2024, time=2024-03-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2229945, encodeId=6eb72229945a9, content=请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Wed Oct 09 13:33:16 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2229720, encodeId=d12d2229e2096, content=10月1日投稿，10月2号收到邮件，没有要WB膜和原始数据，邮件内容如下：我们认为有必要提醒您，由于提交量的增加，在决定将您的手稿发送给同行评审之前，最初的期刊适用性和合规性检查将被推迟。目前，这一阶段平均需要30天，我们知道这比您通常期望我们提供的服务要长得多。请允许我们向您保证，这次延迟只是暂时的。我们知道你选择在《炎症研究杂志》上发表文章，部分原因是我们长期以来的快速发表历史。目前是1A_2的状态，已经过了一周了，难道真的需要等30天么？各位投过的小伙伴个情况持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff4d5246870, createdName=爱臭美的小女孩, createdTime=Tue Oct 08 09:09:31 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237308, encodeId=39a3223e308fd, content=该期刊的审稿速度较快，通常在3-4周内完成同行评审，编辑会在2-14天内做出决定。 对文章的创新性要求较高，文章需使用英语撰写，控制重复率在10%以内，并且包含图表、公式、数据等元素。图片和图表的格式需遵循特定要求，如TIFF、EPS、JPEG格式，彩色图片分辨率需≥300dpi。 该期刊对国人友好，国人发文占比约为60%以上。 生信领域友好，但自引率有所增加，需要注意选择其他自引率较低的期刊作为备选。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 22:31:53 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237007, encodeId=3c39223e00740, content=大家因为找不到审稿人，被拒稿的人多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Thu Nov 14 23:54:16 CST 2024, time=2024-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2236622, encodeId=4a072236622df, content=各位的稿件2e状态持续多久呀？我的已经10天了还没变化……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Nov 13 01:11:58 CST 2024, time=2024-11-13, status=1, ipAttribution=江苏省)]

2024-11-19 ms5000001180195665 来自北京

大家2a用了多久到下一步呀

6 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237984, encodeId=57b0223e9842c, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：16 April 2024 Submission created 18 June 2024 Peer review selection 13 August 2024 Report sent to the Editor-in-Chief 17 August 2024 Report: revise with changes 15 October 2024 Resubmitted manuscript received 8 November 2024 Sent to Editor-in-Chief for acceptance or rejection 14 November 2024 Accepted for publication 之前网站上看到了很多人分享的经验，对自己有一定的帮助，这个时间线供大家参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f279053145, createdName=ms4000002068072868, createdTime=Wed Nov 20 14:35:42 CST 2024, time=2024-11-20, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2237751, encodeId=9e6e223e75126, content=大家2a用了多久到下一步呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Tue Nov 19 10:53:40 CST 2024, time=2024-11-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2238262, encodeId=a3a6223826243, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：目前投出去1周，现在是1AB，不知道还有多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=051e2959338, createdName=caoyuzhi01, createdTime=Thu Nov 21 20:35:25 CST 2024, time=2024-11-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2237772, encodeId=cb0d223e772b9, content=我觉得这个杂志很不错，已online 2篇，靠谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40ac3080545, createdName=liangyan0327, createdTime=Tue Nov 19 12:35:27 CST 2024, time=2024-11-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193170, encodeId=dd4721931e00d, content=wb是要整膜的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Thu Mar 14 14:20:51 CST 2024, time=2024-03-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2229945, encodeId=6eb72229945a9, content=请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Wed Oct 09 13:33:16 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2229720, encodeId=d12d2229e2096, content=10月1日投稿，10月2号收到邮件，没有要WB膜和原始数据，邮件内容如下：我们认为有必要提醒您，由于提交量的增加，在决定将您的手稿发送给同行评审之前，最初的期刊适用性和合规性检查将被推迟。目前，这一阶段平均需要30天，我们知道这比您通常期望我们提供的服务要长得多。请允许我们向您保证，这次延迟只是暂时的。我们知道你选择在《炎症研究杂志》上发表文章，部分原因是我们长期以来的快速发表历史。目前是1A_2的状态，已经过了一周了，难道真的需要等30天么？各位投过的小伙伴个情况持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff4d5246870, createdName=爱臭美的小女孩, createdTime=Tue Oct 08 09:09:31 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237308, encodeId=39a3223e308fd, content=该期刊的审稿速度较快，通常在3-4周内完成同行评审，编辑会在2-14天内做出决定。 对文章的创新性要求较高，文章需使用英语撰写，控制重复率在10%以内，并且包含图表、公式、数据等元素。图片和图表的格式需遵循特定要求，如TIFF、EPS、JPEG格式，彩色图片分辨率需≥300dpi。 该期刊对国人友好，国人发文占比约为60%以上。 生信领域友好，但自引率有所增加，需要注意选择其他自引率较低的期刊作为备选。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 22:31:53 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237007, encodeId=3c39223e00740, content=大家因为找不到审稿人，被拒稿的人多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Thu Nov 14 23:54:16 CST 2024, time=2024-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2236622, encodeId=4a072236622df, content=各位的稿件2e状态持续多久呀？我的已经10天了还没变化……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Nov 13 01:11:58 CST 2024, time=2024-11-13, status=1, ipAttribution=江苏省)]

2024-11-21 caoyuzhi01 来自江苏省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：炎症
经验分享：目前投出去1周，现在是1AB，不知道还有多久啊

3 0

[GetPortalCommentsPageByObjectIdResponse(id=2237984, encodeId=57b0223e9842c, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：16 April 2024 Submission created 18 June 2024 Peer review selection 13 August 2024 Report sent to the Editor-in-Chief 17 August 2024 Report: revise with changes 15 October 2024 Resubmitted manuscript received 8 November 2024 Sent to Editor-in-Chief for acceptance or rejection 14 November 2024 Accepted for publication 之前网站上看到了很多人分享的经验，对自己有一定的帮助，这个时间线供大家参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f279053145, createdName=ms4000002068072868, createdTime=Wed Nov 20 14:35:42 CST 2024, time=2024-11-20, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2237751, encodeId=9e6e223e75126, content=大家2a用了多久到下一步呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Tue Nov 19 10:53:40 CST 2024, time=2024-11-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2238262, encodeId=a3a6223826243, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：目前投出去1周，现在是1AB，不知道还有多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=051e2959338, createdName=caoyuzhi01, createdTime=Thu Nov 21 20:35:25 CST 2024, time=2024-11-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2237772, encodeId=cb0d223e772b9, content=我觉得这个杂志很不错，已online 2篇，靠谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40ac3080545, createdName=liangyan0327, createdTime=Tue Nov 19 12:35:27 CST 2024, time=2024-11-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193170, encodeId=dd4721931e00d, content=wb是要整膜的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Thu Mar 14 14:20:51 CST 2024, time=2024-03-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2229945, encodeId=6eb72229945a9, content=请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Wed Oct 09 13:33:16 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2229720, encodeId=d12d2229e2096, content=10月1日投稿，10月2号收到邮件，没有要WB膜和原始数据，邮件内容如下：我们认为有必要提醒您，由于提交量的增加，在决定将您的手稿发送给同行评审之前，最初的期刊适用性和合规性检查将被推迟。目前，这一阶段平均需要30天，我们知道这比您通常期望我们提供的服务要长得多。请允许我们向您保证，这次延迟只是暂时的。我们知道你选择在《炎症研究杂志》上发表文章，部分原因是我们长期以来的快速发表历史。目前是1A_2的状态，已经过了一周了，难道真的需要等30天么？各位投过的小伙伴个情况持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff4d5246870, createdName=爱臭美的小女孩, createdTime=Tue Oct 08 09:09:31 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237308, encodeId=39a3223e308fd, content=该期刊的审稿速度较快，通常在3-4周内完成同行评审，编辑会在2-14天内做出决定。 对文章的创新性要求较高，文章需使用英语撰写，控制重复率在10%以内，并且包含图表、公式、数据等元素。图片和图表的格式需遵循特定要求，如TIFF、EPS、JPEG格式，彩色图片分辨率需≥300dpi。 该期刊对国人友好，国人发文占比约为60%以上。 生信领域友好，但自引率有所增加，需要注意选择其他自引率较低的期刊作为备选。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 22:31:53 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237007, encodeId=3c39223e00740, content=大家因为找不到审稿人，被拒稿的人多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Thu Nov 14 23:54:16 CST 2024, time=2024-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2236622, encodeId=4a072236622df, content=各位的稿件2e状态持续多久呀？我的已经10天了还没变化……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Nov 13 01:11:58 CST 2024, time=2024-11-13, status=1, ipAttribution=江苏省)]

2024-11-19 liangyan0327 来自广西

我觉得这个杂志很不错，已online 2篇，靠谱

5 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237984, encodeId=57b0223e9842c, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：16 April 2024 Submission created 18 June 2024 Peer review selection 13 August 2024 Report sent to the Editor-in-Chief 17 August 2024 Report: revise with changes 15 October 2024 Resubmitted manuscript received 8 November 2024 Sent to Editor-in-Chief for acceptance or rejection 14 November 2024 Accepted for publication 之前网站上看到了很多人分享的经验，对自己有一定的帮助，这个时间线供大家参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f279053145, createdName=ms4000002068072868, createdTime=Wed Nov 20 14:35:42 CST 2024, time=2024-11-20, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2237751, encodeId=9e6e223e75126, content=大家2a用了多久到下一步呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Tue Nov 19 10:53:40 CST 2024, time=2024-11-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2238262, encodeId=a3a6223826243, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：目前投出去1周，现在是1AB，不知道还有多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=051e2959338, createdName=caoyuzhi01, createdTime=Thu Nov 21 20:35:25 CST 2024, time=2024-11-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2237772, encodeId=cb0d223e772b9, content=我觉得这个杂志很不错，已online 2篇，靠谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40ac3080545, createdName=liangyan0327, createdTime=Tue Nov 19 12:35:27 CST 2024, time=2024-11-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193170, encodeId=dd4721931e00d, content=wb是要整膜的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Thu Mar 14 14:20:51 CST 2024, time=2024-03-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2229945, encodeId=6eb72229945a9, content=请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Wed Oct 09 13:33:16 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2229720, encodeId=d12d2229e2096, content=10月1日投稿，10月2号收到邮件，没有要WB膜和原始数据，邮件内容如下：我们认为有必要提醒您，由于提交量的增加，在决定将您的手稿发送给同行评审之前，最初的期刊适用性和合规性检查将被推迟。目前，这一阶段平均需要30天，我们知道这比您通常期望我们提供的服务要长得多。请允许我们向您保证，这次延迟只是暂时的。我们知道你选择在《炎症研究杂志》上发表文章，部分原因是我们长期以来的快速发表历史。目前是1A_2的状态，已经过了一周了，难道真的需要等30天么？各位投过的小伙伴个情况持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff4d5246870, createdName=爱臭美的小女孩, createdTime=Tue Oct 08 09:09:31 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237308, encodeId=39a3223e308fd, content=该期刊的审稿速度较快，通常在3-4周内完成同行评审，编辑会在2-14天内做出决定。 对文章的创新性要求较高，文章需使用英语撰写，控制重复率在10%以内，并且包含图表、公式、数据等元素。图片和图表的格式需遵循特定要求，如TIFF、EPS、JPEG格式，彩色图片分辨率需≥300dpi。 该期刊对国人友好，国人发文占比约为60%以上。 生信领域友好，但自引率有所增加，需要注意选择其他自引率较低的期刊作为备选。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 22:31:53 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237007, encodeId=3c39223e00740, content=大家因为找不到审稿人，被拒稿的人多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Thu Nov 14 23:54:16 CST 2024, time=2024-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2236622, encodeId=4a072236622df, content=各位的稿件2e状态持续多久呀？我的已经10天了还没变化……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Nov 13 01:11:58 CST 2024, time=2024-11-13, status=1, ipAttribution=江苏省)]

2024-03-14 ms3000001126828781 来自广西

wb是要整膜的吗？

86 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237984, encodeId=57b0223e9842c, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：16 April 2024 Submission created 18 June 2024 Peer review selection 13 August 2024 Report sent to the Editor-in-Chief 17 August 2024 Report: revise with changes 15 October 2024 Resubmitted manuscript received 8 November 2024 Sent to Editor-in-Chief for acceptance or rejection 14 November 2024 Accepted for publication 之前网站上看到了很多人分享的经验，对自己有一定的帮助，这个时间线供大家参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f279053145, createdName=ms4000002068072868, createdTime=Wed Nov 20 14:35:42 CST 2024, time=2024-11-20, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2237751, encodeId=9e6e223e75126, content=大家2a用了多久到下一步呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Tue Nov 19 10:53:40 CST 2024, time=2024-11-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2238262, encodeId=a3a6223826243, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：目前投出去1周，现在是1AB，不知道还有多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=051e2959338, createdName=caoyuzhi01, createdTime=Thu Nov 21 20:35:25 CST 2024, time=2024-11-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2237772, encodeId=cb0d223e772b9, content=我觉得这个杂志很不错，已online 2篇，靠谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40ac3080545, createdName=liangyan0327, createdTime=Tue Nov 19 12:35:27 CST 2024, time=2024-11-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193170, encodeId=dd4721931e00d, content=wb是要整膜的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Thu Mar 14 14:20:51 CST 2024, time=2024-03-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2229945, encodeId=6eb72229945a9, content=请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Wed Oct 09 13:33:16 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2229720, encodeId=d12d2229e2096, content=10月1日投稿，10月2号收到邮件，没有要WB膜和原始数据，邮件内容如下：我们认为有必要提醒您，由于提交量的增加，在决定将您的手稿发送给同行评审之前，最初的期刊适用性和合规性检查将被推迟。目前，这一阶段平均需要30天，我们知道这比您通常期望我们提供的服务要长得多。请允许我们向您保证，这次延迟只是暂时的。我们知道你选择在《炎症研究杂志》上发表文章，部分原因是我们长期以来的快速发表历史。目前是1A_2的状态，已经过了一周了，难道真的需要等30天么？各位投过的小伙伴个情况持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff4d5246870, createdName=爱臭美的小女孩, createdTime=Tue Oct 08 09:09:31 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237308, encodeId=39a3223e308fd, content=该期刊的审稿速度较快，通常在3-4周内完成同行评审，编辑会在2-14天内做出决定。 对文章的创新性要求较高，文章需使用英语撰写，控制重复率在10%以内，并且包含图表、公式、数据等元素。图片和图表的格式需遵循特定要求，如TIFF、EPS、JPEG格式，彩色图片分辨率需≥300dpi。 该期刊对国人友好，国人发文占比约为60%以上。 生信领域友好，但自引率有所增加，需要注意选择其他自引率较低的期刊作为备选。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 22:31:53 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237007, encodeId=3c39223e00740, content=大家因为找不到审稿人，被拒稿的人多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Thu Nov 14 23:54:16 CST 2024, time=2024-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2236622, encodeId=4a072236622df, content=各位的稿件2e状态持续多久呀？我的已经10天了还没变化……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Nov 13 01:11:58 CST 2024, time=2024-11-13, status=1, ipAttribution=江苏省)]

2024-10-09 ms9000002057290162 来自浙江省

请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊

19 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237984, encodeId=57b0223e9842c, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：16 April 2024 Submission created 18 June 2024 Peer review selection 13 August 2024 Report sent to the Editor-in-Chief 17 August 2024 Report: revise with changes 15 October 2024 Resubmitted manuscript received 8 November 2024 Sent to Editor-in-Chief for acceptance or rejection 14 November 2024 Accepted for publication 之前网站上看到了很多人分享的经验，对自己有一定的帮助，这个时间线供大家参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f279053145, createdName=ms4000002068072868, createdTime=Wed Nov 20 14:35:42 CST 2024, time=2024-11-20, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2237751, encodeId=9e6e223e75126, content=大家2a用了多久到下一步呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Tue Nov 19 10:53:40 CST 2024, time=2024-11-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2238262, encodeId=a3a6223826243, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：目前投出去1周，现在是1AB，不知道还有多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=051e2959338, createdName=caoyuzhi01, createdTime=Thu Nov 21 20:35:25 CST 2024, time=2024-11-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2237772, encodeId=cb0d223e772b9, content=我觉得这个杂志很不错，已online 2篇，靠谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40ac3080545, createdName=liangyan0327, createdTime=Tue Nov 19 12:35:27 CST 2024, time=2024-11-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193170, encodeId=dd4721931e00d, content=wb是要整膜的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Thu Mar 14 14:20:51 CST 2024, time=2024-03-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2229945, encodeId=6eb72229945a9, content=请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Wed Oct 09 13:33:16 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2229720, encodeId=d12d2229e2096, content=10月1日投稿，10月2号收到邮件，没有要WB膜和原始数据，邮件内容如下：我们认为有必要提醒您，由于提交量的增加，在决定将您的手稿发送给同行评审之前，最初的期刊适用性和合规性检查将被推迟。目前，这一阶段平均需要30天，我们知道这比您通常期望我们提供的服务要长得多。请允许我们向您保证，这次延迟只是暂时的。我们知道你选择在《炎症研究杂志》上发表文章，部分原因是我们长期以来的快速发表历史。目前是1A_2的状态，已经过了一周了，难道真的需要等30天么？各位投过的小伙伴个情况持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff4d5246870, createdName=爱臭美的小女孩, createdTime=Tue Oct 08 09:09:31 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237308, encodeId=39a3223e308fd, content=该期刊的审稿速度较快，通常在3-4周内完成同行评审，编辑会在2-14天内做出决定。 对文章的创新性要求较高，文章需使用英语撰写，控制重复率在10%以内，并且包含图表、公式、数据等元素。图片和图表的格式需遵循特定要求，如TIFF、EPS、JPEG格式，彩色图片分辨率需≥300dpi。 该期刊对国人友好，国人发文占比约为60%以上。 生信领域友好，但自引率有所增加，需要注意选择其他自引率较低的期刊作为备选。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 22:31:53 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237007, encodeId=3c39223e00740, content=大家因为找不到审稿人，被拒稿的人多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Thu Nov 14 23:54:16 CST 2024, time=2024-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2236622, encodeId=4a072236622df, content=各位的稿件2e状态持续多久呀？我的已经10天了还没变化……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Nov 13 01:11:58 CST 2024, time=2024-11-13, status=1, ipAttribution=江苏省)]

2024-10-08 爱臭美的小女孩来自北京

10月1日投稿，10月2号收到邮件，没有要WB膜和原始数据，邮件内容如下：我们认为有必要提醒您，由于提交量的增加，在决定将您的手稿发送给同行评审之前，最初的期刊适用性和合规性检查将被推迟。目前，这一阶段平均需要30天，我们知道这比您通常期望我们提供的服务要长得多。请允许我们向您保证，这次延迟只是暂时的。我们知道你选择在《炎症研究杂志》上发表文章，部分原因是我们长期以来的快速发表历史。目前是1A_2的状态，已经过了一周了，难道真的需要等30天么？各位投过的小伙伴个情况持续多久？

24 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237984, encodeId=57b0223e9842c, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：16 April 2024 Submission created 18 June 2024 Peer review selection 13 August 2024 Report sent to the Editor-in-Chief 17 August 2024 Report: revise with changes 15 October 2024 Resubmitted manuscript received 8 November 2024 Sent to Editor-in-Chief for acceptance or rejection 14 November 2024 Accepted for publication 之前网站上看到了很多人分享的经验，对自己有一定的帮助，这个时间线供大家参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f279053145, createdName=ms4000002068072868, createdTime=Wed Nov 20 14:35:42 CST 2024, time=2024-11-20, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2237751, encodeId=9e6e223e75126, content=大家2a用了多久到下一步呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Tue Nov 19 10:53:40 CST 2024, time=2024-11-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2238262, encodeId=a3a6223826243, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：目前投出去1周，现在是1AB，不知道还有多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=051e2959338, createdName=caoyuzhi01, createdTime=Thu Nov 21 20:35:25 CST 2024, time=2024-11-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2237772, encodeId=cb0d223e772b9, content=我觉得这个杂志很不错，已online 2篇，靠谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40ac3080545, createdName=liangyan0327, createdTime=Tue Nov 19 12:35:27 CST 2024, time=2024-11-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193170, encodeId=dd4721931e00d, content=wb是要整膜的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Thu Mar 14 14:20:51 CST 2024, time=2024-03-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2229945, encodeId=6eb72229945a9, content=请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Wed Oct 09 13:33:16 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2229720, encodeId=d12d2229e2096, content=10月1日投稿，10月2号收到邮件，没有要WB膜和原始数据，邮件内容如下：我们认为有必要提醒您，由于提交量的增加，在决定将您的手稿发送给同行评审之前，最初的期刊适用性和合规性检查将被推迟。目前，这一阶段平均需要30天，我们知道这比您通常期望我们提供的服务要长得多。请允许我们向您保证，这次延迟只是暂时的。我们知道你选择在《炎症研究杂志》上发表文章，部分原因是我们长期以来的快速发表历史。目前是1A_2的状态，已经过了一周了，难道真的需要等30天么？各位投过的小伙伴个情况持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff4d5246870, createdName=爱臭美的小女孩, createdTime=Tue Oct 08 09:09:31 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237308, encodeId=39a3223e308fd, content=该期刊的审稿速度较快，通常在3-4周内完成同行评审，编辑会在2-14天内做出决定。 对文章的创新性要求较高，文章需使用英语撰写，控制重复率在10%以内，并且包含图表、公式、数据等元素。图片和图表的格式需遵循特定要求，如TIFF、EPS、JPEG格式，彩色图片分辨率需≥300dpi。 该期刊对国人友好，国人发文占比约为60%以上。 生信领域友好，但自引率有所增加，需要注意选择其他自引率较低的期刊作为备选。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 22:31:53 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237007, encodeId=3c39223e00740, content=大家因为找不到审稿人，被拒稿的人多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Thu Nov 14 23:54:16 CST 2024, time=2024-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2236622, encodeId=4a072236622df, content=各位的稿件2e状态持续多久呀？我的已经10天了还没变化……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Nov 13 01:11:58 CST 2024, time=2024-11-13, status=1, ipAttribution=江苏省)]

2024-11-16 ms1000001788822136 来自上海

该期刊的审稿速度较快，通常在3-4周内完成同行评审，编辑会在2-14天内做出决定。
对文章的创新性要求较高，文章需使用英语撰写，控制重复率在10%以内，并且包含图表、公式、数据等元素。图片和图表的格式需遵循特定要求，如TIFF、EPS、JPEG格式，彩色图片分辨率需≥300dpi。
该期刊对国人友好，国人发文占比约为60%以上。
生信领域友好，但自引率有所增加，需要注意选择其他自引率较低的期刊作为备选。

6 0

[GetPortalCommentsPageByObjectIdResponse(id=2237984, encodeId=57b0223e9842c, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：16 April 2024 Submission created 18 June 2024 Peer review selection 13 August 2024 Report sent to the Editor-in-Chief 17 August 2024 Report: revise with changes 15 October 2024 Resubmitted manuscript received 8 November 2024 Sent to Editor-in-Chief for acceptance or rejection 14 November 2024 Accepted for publication 之前网站上看到了很多人分享的经验，对自己有一定的帮助，这个时间线供大家参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f279053145, createdName=ms4000002068072868, createdTime=Wed Nov 20 14:35:42 CST 2024, time=2024-11-20, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2237751, encodeId=9e6e223e75126, content=大家2a用了多久到下一步呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Tue Nov 19 10:53:40 CST 2024, time=2024-11-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2238262, encodeId=a3a6223826243, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：目前投出去1周，现在是1AB，不知道还有多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=051e2959338, createdName=caoyuzhi01, createdTime=Thu Nov 21 20:35:25 CST 2024, time=2024-11-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2237772, encodeId=cb0d223e772b9, content=我觉得这个杂志很不错，已online 2篇，靠谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40ac3080545, createdName=liangyan0327, createdTime=Tue Nov 19 12:35:27 CST 2024, time=2024-11-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193170, encodeId=dd4721931e00d, content=wb是要整膜的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Thu Mar 14 14:20:51 CST 2024, time=2024-03-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2229945, encodeId=6eb72229945a9, content=请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Wed Oct 09 13:33:16 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2229720, encodeId=d12d2229e2096, content=10月1日投稿，10月2号收到邮件，没有要WB膜和原始数据，邮件内容如下：我们认为有必要提醒您，由于提交量的增加，在决定将您的手稿发送给同行评审之前，最初的期刊适用性和合规性检查将被推迟。目前，这一阶段平均需要30天，我们知道这比您通常期望我们提供的服务要长得多。请允许我们向您保证，这次延迟只是暂时的。我们知道你选择在《炎症研究杂志》上发表文章，部分原因是我们长期以来的快速发表历史。目前是1A_2的状态，已经过了一周了，难道真的需要等30天么？各位投过的小伙伴个情况持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff4d5246870, createdName=爱臭美的小女孩, createdTime=Tue Oct 08 09:09:31 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237308, encodeId=39a3223e308fd, content=该期刊的审稿速度较快，通常在3-4周内完成同行评审，编辑会在2-14天内做出决定。 对文章的创新性要求较高，文章需使用英语撰写，控制重复率在10%以内，并且包含图表、公式、数据等元素。图片和图表的格式需遵循特定要求，如TIFF、EPS、JPEG格式，彩色图片分辨率需≥300dpi。 该期刊对国人友好，国人发文占比约为60%以上。 生信领域友好，但自引率有所增加，需要注意选择其他自引率较低的期刊作为备选。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 22:31:53 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237007, encodeId=3c39223e00740, content=大家因为找不到审稿人，被拒稿的人多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Thu Nov 14 23:54:16 CST 2024, time=2024-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2236622, encodeId=4a072236622df, content=各位的稿件2e状态持续多久呀？我的已经10天了还没变化……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Nov 13 01:11:58 CST 2024, time=2024-11-13, status=1, ipAttribution=江苏省)]

2024-11-14 ms5000001180195665 来自北京

大家因为找不到审稿人，被拒稿的人多吗

5 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237984, encodeId=57b0223e9842c, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：16 April 2024 Submission created 18 June 2024 Peer review selection 13 August 2024 Report sent to the Editor-in-Chief 17 August 2024 Report: revise with changes 15 October 2024 Resubmitted manuscript received 8 November 2024 Sent to Editor-in-Chief for acceptance or rejection 14 November 2024 Accepted for publication 之前网站上看到了很多人分享的经验，对自己有一定的帮助，这个时间线供大家参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f279053145, createdName=ms4000002068072868, createdTime=Wed Nov 20 14:35:42 CST 2024, time=2024-11-20, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2237751, encodeId=9e6e223e75126, content=大家2a用了多久到下一步呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Tue Nov 19 10:53:40 CST 2024, time=2024-11-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2238262, encodeId=a3a6223826243, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：目前投出去1周，现在是1AB，不知道还有多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=051e2959338, createdName=caoyuzhi01, createdTime=Thu Nov 21 20:35:25 CST 2024, time=2024-11-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2237772, encodeId=cb0d223e772b9, content=我觉得这个杂志很不错，已online 2篇，靠谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40ac3080545, createdName=liangyan0327, createdTime=Tue Nov 19 12:35:27 CST 2024, time=2024-11-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193170, encodeId=dd4721931e00d, content=wb是要整膜的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Thu Mar 14 14:20:51 CST 2024, time=2024-03-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2229945, encodeId=6eb72229945a9, content=请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Wed Oct 09 13:33:16 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2229720, encodeId=d12d2229e2096, content=10月1日投稿，10月2号收到邮件，没有要WB膜和原始数据，邮件内容如下：我们认为有必要提醒您，由于提交量的增加，在决定将您的手稿发送给同行评审之前，最初的期刊适用性和合规性检查将被推迟。目前，这一阶段平均需要30天，我们知道这比您通常期望我们提供的服务要长得多。请允许我们向您保证，这次延迟只是暂时的。我们知道你选择在《炎症研究杂志》上发表文章，部分原因是我们长期以来的快速发表历史。目前是1A_2的状态，已经过了一周了，难道真的需要等30天么？各位投过的小伙伴个情况持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff4d5246870, createdName=爱臭美的小女孩, createdTime=Tue Oct 08 09:09:31 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237308, encodeId=39a3223e308fd, content=该期刊的审稿速度较快，通常在3-4周内完成同行评审，编辑会在2-14天内做出决定。 对文章的创新性要求较高，文章需使用英语撰写，控制重复率在10%以内，并且包含图表、公式、数据等元素。图片和图表的格式需遵循特定要求，如TIFF、EPS、JPEG格式，彩色图片分辨率需≥300dpi。 该期刊对国人友好，国人发文占比约为60%以上。 生信领域友好，但自引率有所增加，需要注意选择其他自引率较低的期刊作为备选。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 22:31:53 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237007, encodeId=3c39223e00740, content=大家因为找不到审稿人，被拒稿的人多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Thu Nov 14 23:54:16 CST 2024, time=2024-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2236622, encodeId=4a072236622df, content=各位的稿件2e状态持续多久呀？我的已经10天了还没变化……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Nov 13 01:11:58 CST 2024, time=2024-11-13, status=1, ipAttribution=江苏省)]

2024-11-13 ms8000001052932104 来自江苏省

各位的稿件2e状态持续多久呀？我的已经10天了还没变化……

5 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务